Literature DB >> 1658205

Degenerate primers based on highly conserved regions of amino acid sequence in papillomaviruses can be used in a generalized polymerase chain reaction to detect productive human papillomavirus infection.

P J Snijders1, C J Meijer, J M Walboomers.   

Abstract

Conserved amino acid sequences within the L1 open reading frame of the human papillomavirus (HPV) genome were used as a basis to design two degenerate primers (GP17 and GP18) and one general probe (GPR22) which direct polymerase chain reaction (PCR) amplification and subsequent detection of a 620 to 660 bp DNA fragment. The conserved nature of the primers and probe was tested experimentally on a panel of 24 cloned HPV DNAs isolated from cutaneous and mucosal lesions, including HPV-2a and -57, which are known to be associated with lesions at both anatomical sites. The sensitivity of this PCR test was at the level of genomic Southern blot analysis, indicating that HPV infections producing high copy numbers can be detected. Positive results were obtained with DNA extracted from clinical samples of genital and cutaneous origin.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1658205     DOI: 10.1099/0022-1317-72-11-2781

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  10 in total

1.  Identification of six putative novel human papillomaviruses (HPV) and characterization of candidate HPV type 87.

Authors:  S Menzo; A Monachetti; C Trozzi; A Ciavattini; G Carloni; P E Varaldo; M Clementi
Journal:  J Virol       Date:  2001-12       Impact factor: 5.103

Review 2.  DNA fingerprinting of medically important microorganisms by use of PCR.

Authors:  A van Belkum
Journal:  Clin Microbiol Rev       Date:  1994-04       Impact factor: 26.132

3.  A sensitive, type-specific, fluorogenic probe assay for detection of human papillomavirus DNA.

Authors:  D C Swan; R A Tucker; B P Holloway; J P Icenogle
Journal:  J Clin Microbiol       Date:  1997-04       Impact factor: 5.948

4.  Rapid real time PCR to distinguish between high risk human papillomavirus types 16 and 18.

Authors:  H A Cubie; A L Seagar; E McGoogan; J Whitehead; A Brass; M J Arends; M W Whitley
Journal:  Mol Pathol       Date:  2001-02

5.  Phylogenetic analysis of 48 papillomavirus types and 28 subtypes and variants: a showcase for the molecular evolution of DNA viruses.

Authors:  S Y Chan; H U Bernard; C K Ong; S P Chan; B Hofmann; H Delius
Journal:  J Virol       Date:  1992-10       Impact factor: 5.103

6.  Prospective study on cervical neoplasia: presence of HPV DNA in cytological smears precedes the development of cervical neoplastic lesions.

Authors:  R Tachezy; M Saláková; E Hamsíková; J Kanka; A Havránková; V Vonka
Journal:  Sex Transm Infect       Date:  2003-06       Impact factor: 3.519

7.  Detection of human papillomavirus DNA in cutaneous squamous cell carcinoma among immunocompetent individuals.

Authors:  Maryam M Asgari; Nancy B Kiviat; Cathy W Critchlow; Joshua E Stern; Zsolt B Argenyi; Gregory J Raugi; Daniel Berg; Peter B Odland; Stephen E Hawes; Ethel-Michele de Villiers
Journal:  J Invest Dermatol       Date:  2008-01-10       Impact factor: 8.551

8.  Processing of long-stored archival cervical smears for human papillomavirus detection by the polymerase chain reaction.

Authors:  A M de Roda Husman; P J Snijders; H V Stel; A J van den Brule; C J Meijer; J M Walboomers
Journal:  Br J Cancer       Date:  1995-08       Impact factor: 7.640

9.  Benign proliferative epithelial lesions of oral mucosa are infrequently associated with α-, β-, or γ human papillomaviruses.

Authors:  Sirli Kerge; Jessi Vuorinen; Saija Hurme; Tero Soukka; Tarik Gheit; Massimo Tommasino; Stina Syrjänen; Jaana Rautava
Journal:  Laryngoscope Investig Otolaryngol       Date:  2018-12-03

Review 10.  Role of human papillomavirus and its detection in potentially malignant and malignant head and neck lesions: updated review.

Authors:  Ajay Kumar Chaudhary; Mamta Singh; Shanthy Sundaram; Ravi Mehrotra
Journal:  Head Neck Oncol       Date:  2009-06-25
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.